TSE:NVCN Neovasc (NVCN) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Neovasc Stock (TSE:NVCN) 30 days 90 days 365 days Advanced Chart Remove Ads Get Neovasc alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume399 shsAverage Volume2,123 shsMarket CapitalizationC$110.81 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewNeovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.Read More… Remove Ads Receive NVCN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Neovasc and its competitors with MarketBeat's FREE daily newsletter. Email Address NVCN Stock News HeadlinesAptose Biosciences Inc (APS)February 14, 2024 | investing.comClosing Bell: Neovasc Inc up on Thursday (NVCN)April 6, 2023 | theglobeandmail.comTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.April 2, 2025 | Porter & Company (Ad)Neovasc: Top 25 Performing Stocks Year-to-Date on Toronto Stock Exchange (NVCN)February 1, 2023 | theglobeandmail.comShockwave Medical to Acquire NeovascJanuary 17, 2023 | finance.yahoo.comShockwave Medical to Buy Neovasc for $75 MillionJanuary 17, 2023 | marketwatch.comSHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Neovasc Inc. (NVCN)January 17, 2023 | benzinga.comNeovasc Inc. (NVCN) Q3 2022 Earnings Call TranscriptNovember 11, 2022 | seekingalpha.comSee More Headlines NVCN Stock Analysis - Frequently Asked Questions How do I buy shares of Neovasc? Shares of NVCN stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of Neovasc own? Based on aggregate information from My MarketBeat watchlists, some other companies that Neovasc investors own include Bionano Genomics (BNGO) and Meta Platforms (META). Industry, Sector and Symbol Stock ExchangeTSE SectorManufacturing Industry Surgical & Medical Instrument Manufacturing Sub-IndustryMedical Equipment Current SymbolTSE:NVCN CIKN/A Webwww.neovasc.com Phone16042704344FaxN/AEmployees50Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)C($20.44) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeC$-33,520,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-78.25% Return on Assets-32.95% Debt Debt-to-Equity Ratio44.86 Current Ratio8.44 Quick Ratio8.04 Sales & Book Value Annual SalesC$3.11 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow1.05 Book ValueC$10.22 per share Price / BookN/AMiscellaneous Outstanding Shares2,760,000Free FloatN/AMarket CapC$110.81 million OptionableNot Optionable Beta2.01 5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report This page (TSE:NVCN) was last updated on 4/2/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredDOGE tax surpriseElon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...Altimetry | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neovasc Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Neovasc With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.